These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25895868)

  • 21. New radiosensitization treatment (KORTUC I) using hydrogen peroxide solution-soaked gauze bolus for unresectable and superficially exposed neoplasms.
    Ogawa Y; Ue H; Tsuzuki K; Tadokoro M; Miyatake K; Sasaki T; Yokota N; Hamada N; Kariya S; Hitomi J; Nishioka A; Nakajima K; Ikeda M; Sano S; Inomata T
    Oncol Rep; 2008 Jun; 19(6):1389-94. PubMed ID: 18497941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AGuIX nanoparticles enhance ionizing radiation-induced ferroptosis on tumor cells by targeting the NRF2-GPX4 signaling pathway.
    Sun H; Cai H; Xu C; Zhai H; Lux F; Xie Y; Feng L; Du L; Liu Y; Sun X; Wang Q; Song H; He N; Zhang M; Ji K; Wang J; Gu Y; Leduc G; Doussineau T; Wang Y; Liu Q; Tillement O
    J Nanobiotechnology; 2022 Oct; 20(1):449. PubMed ID: 36242003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calibration-quality cancer nanotherapeutics.
    Perry JL; Kai MP; Reuter KG; Bowerman C; Christopher Luft J; DeSimone JM
    Cancer Treat Res; 2015; 166():275-91. PubMed ID: 25895873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of nano-sensitizers in radiation therapy of metastatic tumors.
    Thanekar AM; Sankaranarayanan SA; Rengan AK
    Cancer Treat Res Commun; 2021; 26():100303. PubMed ID: 33454575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New and emerging radiosensitizers and radioprotectors.
    Spalding AC; Lawrence TS
    Cancer Invest; 2006; 24(4):444-56. PubMed ID: 16777698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
    Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
    Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanomaterials for enhanced immunity as an innovative paradigm in nanomedicine.
    Seth A; Oh DB; Lim YT
    Nanomedicine (Lond); 2015; 10(6):959-75. PubMed ID: 25867860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of base excision repair potentiates iododeoxyuridine-induced cytotoxicity and radiosensitization.
    Taverna P; Hwang HS; Schupp JE; Radivoyevitch T; Session NN; Reddy G; Zarling DA; Kinsella TJ
    Cancer Res; 2003 Feb; 63(4):838-46. PubMed ID: 12591735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RRx-001, A novel dinitroazetidine radiosensitizer.
    Oronsky B; Scicinski J; Ning S; Peehl D; Oronsky A; Cabrales P; Bednarski M; Knox S
    Invest New Drugs; 2016 Jun; 34(3):371-7. PubMed ID: 26841903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiosensitization of tumour cells by cantharidin and some analogues.
    Price WA; Stobbe CC; Park SJ; Chapman JD
    Int J Radiat Biol; 2004 Apr; 80(4):269-79. PubMed ID: 15204704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of radiosensitization by halogenated pyrimidines: effect of BrdU on cell killing and interphase chromosome breakage in radiation-sensitive cells.
    Iliakis G; Pantelias G; Kurtzman S
    Radiat Res; 1991 Jan; 125(1):56-64. PubMed ID: 1986401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Hsp90: a multitarget approach to radiosensitization.
    Camphausen K; Tofilon PJ
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4326-30. PubMed ID: 17671112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of cell cycle perturbations in the combination therapy of chemotherapeutic agents and radiation.
    Pauwels B; Wouters A; Peeters M; Vermorken JB; Lardon F
    Future Oncol; 2010 Sep; 6(9):1485-96. PubMed ID: 20919831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphological Effects and In Vitro Biological Mechanisms of Radiation-Induced Cell Killing by Gold Nanomaterials.
    Jenkins SV; Jung S; Jamshidi-Parsian A; Borrelli MJ; Dings RPM; Griffin RJ
    ACS Appl Mater Interfaces; 2023 Dec; 15(50):58241-58250. PubMed ID: 38059477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indomethacin lowers the threshold thermal exposure for hyperthermic radiosensitization and heat-shock inhibition of ionizing radiation-induced activation of NF-kappaB.
    Locke JE; Bradbury CM; Wei SJ; Shah S; Rene LM; Clemens RA; Roti Roti J; Horikoshi N; Gius D
    Int J Radiat Biol; 2002 Jun; 78(6):493-502. PubMed ID: 12065054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoparticles for thermal cancer therapy.
    Day ES; Morton JG; West JL
    J Biomech Eng; 2009 Jul; 131(7):074001. PubMed ID: 19640133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New radiosensitizing regimens, drugs, prodrugs, and candidates.
    Vallerga AK; Zarling DA; Kinsella TJ
    Clin Adv Hematol Oncol; 2004 Dec; 2(12):793-805. PubMed ID: 16166960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanotechnology in radiation oncology.
    Wang AZ; Tepper JE
    J Clin Oncol; 2014 Sep; 32(26):2879-85. PubMed ID: 25113769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An approach to the radiosensitization of human tumors.
    Kinsella TJ
    Cancer J Sci Am; 1996; 2(4):184-93. PubMed ID: 9166528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiosensitization and cell kinetics: clinical implications for S-phase-specific radiosensitizers.
    Kinsella TJ
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):41-7. PubMed ID: 1641656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.